DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group

Authors:
  • INInko Nimmrich
    Inko Nimmrich
  • TKThomas Koenig
    Thomas Koenig
  • SESerenella Eppenberger-Castori
    Serenella Eppenberger-Castori
  • IBInga Bohlmann
    Inga Bohlmann
  • APAngelo Paradiso
    Angelo Paradiso
  • FSFrédérique Spyratos
    Frédérique Spyratos
  • CTChristoph Thomssen
    Christoph Thomssen
  • VMVolkmar Mueller
    Volkmar Mueller
  • JNJörg Nährig
    Jörg Nährig
  • FSFrancesco Schittulli
    Francesco Schittulli
  • RKRonald Kates
    Ronald Kates

Abstract
No abstract available

This publication has 29 references indexed in Scilit: